Illicit Drugs Bought Off Internet May Be Poisons, Experts
THURSDAY, Feb. 9 (HealthDay News) -- A case study of two men who
were poisoned and turned blue after ingesting what they thought was
a recreational drug that they had bought on the Internet highlights
the dangers of such purchases, a new report claims.
The case study appears in the Feb. 10 issue of the
Morbidity and Mortality Weekly Report, which is published by the U.S. Centers for Disease Control and Prevention.
The term "research chemicals" is a phrase used to illegally sell
stimulants on the Internet, to avoid regulations that ban their
use, the report authors said.
The authors described the case of two Oregon men who believed
they had bought the designer amphetamine derivative 2C-E online.
But the product they actually received was aniline, a highly toxic
Even though these research chemicals all carry a warning label
that they are "not for human consumption," the two men ingested the
chemical. They quickly suffered a severe reaction as their
hemoglobin was converted to methemoglobin, a molecule that prevents
red blood cells from carrying oxygen.
The men's skin turned blue due to the lack of oxygen in their
blood and one of them lost consciousness, said report author Dr.
Shana Kusin and colleagues from the Oregon Poison Center.
The men were saved after poison center and health department
officials rapidly identified the chemical and the proper
The incident illustrates the potentially life-threatening risks
of buying so-called "research chemicals" over the Internet, the
report authors concluded.
The U.S. National Institute on Drug Abuse has more about
drug abuse and addiction.
Copyright © 2012
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.